WILSON WOLF MANUFACTURING CORPORATION
ATTACK T cell therapy manufacturing process and associated cell culture devices for cancer immunotherapy
- Sector
- Biotech
- Total capital
- $6.3M
- Federal grants
- $4M
- 3 awards · 2015–2018
- Rank in peer group#235 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $2.3M
- 48 awards · Health and Human S
- Rank in Biotech#130 of 4373
- Granted patents
- 4
- 15 pending · first 2017
- Rank in peer group#85 of 514
Capital timeline
Latest events
- Federal contractHealth and Human S · G-REX500M-CS And G-rex Cap, 48MM Teal, Vented, Gamma Irradiated$21K
- Federal contractHealth and Human S · G-rex Cap, 48MM Teal, Vented, Gamma Irradiated$21K
- Federal contractHealth and Human S · Biological And Reagents$15K
- Federal contractHealth and Human S · Laboratory Supplies$15K
- Federal contractHealth and Human S · Biologicals & Reagents$15K
- Federal contractHealth and Human S · Biologicals And Reagents$15K
- Federal contractHealth and Human S · Biologicals And Reagents$24K
Show 43 earlier federal awards
- Federal contractHealth and Human S · Biologicals And Reagents$15K
- Federal contractHealth and Human S · Biologicals And Reagents$24K
- Federal contractHealth and Human S · Biologicals And Reagents$24K
- Federal contractHealth and Human S · Biologicals And Reagents$25K
- Federal contractHealth and Human S · G-REX500M-CS Gas Permeable Cell Culture Device - 2 Pack Box$169K
- Federal contractHealth and Human S · Biologicals And Reagents$25K
- Federal contractHealth and Human S · Biologicals And Reagents$25K
- Federal contractHealth and Human S · Biologicals And Reagents$25K
- Federal contractHealth and Human S · Drugs And Biologicals$25K
- Federal contractHealth and Human S · Drugs And Biologicals$24K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [18-008083]$30K
- Federal grantHealth and Human S · Phase II · Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization$924K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing/lab Supplies/somerville$21K
- Federal contractHealth and Human S · Devices$21K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [17-011083]$74K
- Federal grantHealth and Human S · Phase II · Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization$1.5M
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [17-002568]$13K
- Federal contractHealth and Human S · Igf::ot::igf$4K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [16-012785]$35K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [16-012934]$12K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [16-012562]$4K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [16-010243]$4K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [16-002778]$4K
- Federal contractHealth and Human S · Igf::ot::igf HHSN261201200040I Option Period 3 - GREX100 Gas Permeable Cell Culture Devices$288K
- Federal contractHealth and Human S · Igf::ct::igf Provide Gas Permeable Cell Culture Devices For Continuing Studies Of Tumor Infiltrating Lymphocytes$121K
- Federal grantHealth and Human S · Phase II · Overcoming the last barrier to commercialization of virus-specific T cell therapy$1.6M
- Federal contractHealth and Human S · Igf::ct::igf Provide Listed Items Needed To Combat Tumor Infiltrating Lymphocytes$23K
- Federal contractHealth and Human S · Laboratory Equipment And Supplies$23K
- Federal contractHealth and Human S · Igf::cl::igf Wilson Wolf Manufacturing CORPORATION:1174301 [15-000369]$25K
- Federal contractHealth and Human S · Igf::ot::igf HHSN261201200040I Option Period 2 - GREX100 Gas Permeable Cell Culture Device.$206K
- Federal contractHealth and Human S · 14-014064 Catalog Number 81100MCS Grex 100M Closed System Gas Permeable Cell Culture Device$24K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [14-014913]$5K
- Federal contractHealth and Human S · Igf::ct::igf Provide Culture Flasks For Critically Ill Patients$23K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [14-006354]$13K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [14-005397]$5K
- Federal contractHealth and Human S · Igf::ot::igf Option Period 1: GREX100 Gas Permeable Cell Culture Devices$265K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [13-011521]$5K
- Federal contractHealth and Human S · Wilson Wolf Manufacturing CORPORATION:1174301 [13-012869]$16K
- Federal contractHealth and Human S · Wilson Wolf GREX100 Gas Permeable Cell Culture Devices$387K
- Federal contractHealth and Human S · Other Functions: G-REX100 Gas Permeable Cell Culture Device.$25K
- Federal contractHealth and Human S · G-REX100 Culture Flasks$77K
- Federal contractHealth and Human S · GP500 Gas Permeable Flasks / Catalog # 80500S$39K
- Federal contractHealth and Human S · TAS::75 3966::TAS P176204 Gas Permeable Culturware$5K
Federal awards are summed by year (50 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#235 · top 46%
- Granted patents#85 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 19- GrantedProcess for T Cell ExpansionUSPTOUS 11,963,979
- GrantedMethods Of Growing Tumor Infiltrating Lymphocytes In Gas-permeable ContainersUSPTOUS 11,401,503
- GrantedHighly Efficient Gas Permeable Devices And Methods For Culturing CellsUSPTOUS 11,377,635
Show all 19 patent records
- Process for T Cell ExpansionApr 23, 2024 · US 11,963,979Granted
- Methods Of Growing Tumor Infiltrating Lymphocytes In Gas-permeable ContainersAug 2, 2022 · US 11,401,503Granted
- Highly Efficient Gas Permeable Devices And Methods For Culturing CellsJul 5, 2022 · US 11,377,635Granted
- Process For T Cell ExpansionMay 19, 2022 · Application 17586698Pending
- Highly Efficient Gas Permeable Devices And Methods For Culturing CellsAug 15, 2017 · US 9,732,317Granted
- Methods Of Growing Tumor Infiltrating Lymphocytes In Gas-permeable ContainersJun 1, 2017 · Application 15375289Pending
- Improved Methods Of Cell Culture For Adoptive Cell TherapyApplication PCTUS2010059591Pending
- Improved Gas Permeable Cell Culture Device And Method Of UseApplication PCTUS2009049944Pending
- Cell ContainerApplication PCTUS2008062687Pending
- Highly Efficient Devices And Methods For Culturing CellsApplication PCTUS2007025110Pending
- Highly Efficient Gas Permeable Devices And Methods For Culturing CellsApplication PCTUS2007025108Pending
- Compartmentalized Device For Cell Culture, Cell Processing And Sample DialysisApplication PCTUS2004037388Pending
- Dialysis CartridgeApplication PCTUS2004036838Pending
- Cell Culture Methods And Devices Utilizing Gas Permeable MaterialsApplication PCTUS2004033297Pending
- Improved Methods Of Genetically Modifying Animal CellsApplication PCTUS2014057030Pending
- Closed System Device And Methods For Gas Permeable Cell Culture ProcessApplication PCTUS2014043914Pending
- Improved Methods Of Cell Culture For Adoptive Cell TherapyApplication PCTUS2013045209Pending
- Improved Methods Of Cell Culture For Adoptive Cell TherapyApplication PCTUS2013041861Pending
- Methods Of Growing Tumor Infiltrating Lymphocytes In Gas-permeable ContainersApplication PCTUS2012029744Pending
Related companies, and why
- ViraCyte LLCShares a founder: WILSON, JOHN
- Vetigenics LLCSimilar federal contract value in Biotech · $2.4M in contracts
- DIAGNOLOGIX, LLCSimilar federal contract value in Biotech · $2.4M in contracts
- CHROMATAN INCSimilar federal contract value in Biotech · $2.3M in contracts
- MODULATION THERAPEUTICS, INC.Similar federal contract value in Biotech · $2.3M in contracts
- VIEWPOINT MOLECULAR TARGETING, INC.Similar federal contract value in Biotech · $2.2M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .